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ABSTRACT
Objective: The underutilisation of venous
thromboembolism (VTE) prophylaxis is still a problem
in the UK despite the emergence of national guidelines
and incentives to increase the number of patients
undergoing VTE risk assessments. Our objective was
to examine the reasons doctors gave for not
prescribing enoxaparin when recommended by an
electronic VTE risk assessment alert.
Design: We used a qualitative research design to
conduct a thematic analysis of free text entered into an
electronic prescribing system.
Setting: The study took place in a large University
teaching hospital, which has a locally developed
electronic prescribing system known as PICS
(Prescribing, Information and Communication System).
Participants: We extracted prescription data from all
inpatient admissions over a 7-month period in 2012
using the audit database of PICS.
Intervention: The completion of the VTE risk
assessment form introduced into the hospital-wide
electronic prescribing and health records system is
mandatory. Where doctors do not prescribe VTE
prophylaxis when recommended, they are asked to
provide a reason for this decision. The free-text field was
introduced in May 2012.
Primary and secondary outcome measures: Free-
text reasons for not prescribing enoxaparin when
recommended were thematically coded.
Results: A total of 1136 free-text responses from 259
doctors were collected in the time period and 1206
separate reasons were analysed and coded. 389 reasons
(32.3%) for not prescribing enoxaparin were coded as
being due to ‘clinical judgment’; in 288 (23.9%) of the
responses, doctors were going to reassess the patient or
prescribe enoxaparin; and in 245 responses (20.3%), the
system was seen to have produced an inappropriate alert.
Conclusions: In order to increase specificity of
warnings and avoid users developing alert fatigue, it is
essential that an evaluation of user responses and/or end
user feedback as to the appropriateness and timing of
alerts is obtained.
INTRODUCTION
The early identification of patients at risk of
venous thromboembolism (VTE) and pre-
scription of prophylaxis, where appropriate,
are important measures in preventing the
morbidity and mortality associated with
hospital-acquired deep vein thrombosis and/
or pulmonary embolism. VTE contributes to
up to 10% of hospital deaths,1 2 and it is esti-
mated that 25 000 people in the UK die each
year from preventable hospital-acquired
VTE.3 In the past decade, evidence-based
guidelines outlining the importance of VTE
prevention have been published
Strengths and limitations of this study
▪ This study addresses an important topic, as
venous thromboembolism (VTE) prophylaxis is
not always prescribed as recommended in sec-
ondary care.
▪ The hospital in the study has its own locally
developed electronic prescribing system with
embedded Clinical Decision Support (CDS) in
which alerts are specifically designed to encour-
age VTE prophylaxis (eg, prescribing of
enoxaparin).
▪ The study used data collected immediately after
the implementation of a unique free-text feature
within the CDS system, in which doctors can
provide reasons for not prescribing enoxaparin.
▪ The data have allowed us to highlight a number
of strengths and limitations of using CDS to
encourage doctors to appropriately prescribe
enoxaparin in secondary care.
▪ However, we are unable to determine whether
the responses that were provided were reliable
and we were also unable to take into account
cases in which no free-text response was
provided.
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internationally.4–7 In England, there has been an
increased emphasis on programmes to educate clinicians
and to incentivise hospital trusts to increase VTE risk
assessment completion on admission. From June 2010,
the Commissioning for Quality and Innovation
(CQUIN) payment framework required all acute trusts
in the UK to assess 90% of patients admitted for the risk
of VTE in order to receive 1.5% of their funding.8 The
Care Quality Commission is responsible for monitoring
National Health Service (NHS) trusts’ performance on
the new Quality Standards throughout the UK and col-
lects data each month on the number of VTE risk assess-
ments completed.9 Despite the increase in VTE risk
assessment completion, VTE prophylaxis is still underuti-
lised and there is some evidence of poor adherence to
the published guidelines.10–13
In the UK, computer-based rather than paper-based
Clinical Decision Support (CDS) is gaining popularity as
a way of prompting or guiding clinicians in the second-
ary care setting to prescribe appropriately. Changes to
physicians’ adherence to processes of care by computer
reminders have been found to be modest on the
whole,14 but electronic alerts and computerised CDS
have been found to increase the prescription of throm-
boprophylaxis in hospitalised medical patients.15–18
While other studies have been undertaken to under-
stand why physicians do not follow clinical guidelines19
and VTE prophylaxis guidelines specifically,20 few have
been able to ask clinicians why prophylaxis has not been
prescribed at the point of recommendation.
In this study, we were interested in doctors’ responses
to a mandatory free-text field completion when acknow-
ledging a decision support alert specific to the circum-
stance when a VTE risk assessment suggests prophylaxis
but no prescription was completed. Nearly every patient
(99%) admitted to this hospital now has their risk of
developing VTE assessed on admission.21 However, the
trust quality report from 2012 to 2013 identified that
enoxaparin was not prescribed in 34.1% of cases when
recommended by electronic risk assessment.22 We
wanted to identify cases where the system was alerting
inappropriately and we wished to identify where the
system could lead to user frustration and ‘workarounds’
being employed to save time and ease the workload.
METHODS
This study was conducted under the umbrella of a larger
research project funded by the National Institute for
Health Research, for which ethical approval was gained.
This study involved the use of secondary data collected
in the course of normal care and had no patient identi-
fiers or patient-sensitive information, so it was anon-
ymised to the researchers at the point of access.
Setting
This study was conducted in a large NHS university hos-
pital, which has a locally developed electronic
prescribing system known as PICS (Prescribing,
Information and Communication System). PICS is in
operation throughout all (approximately 1200) inpatient
beds and for all prescribing. The system was first
installed in the renal unit 15 years ago23 and now covers
general and specialist medical and surgical specialties.
For the purpose of this study, a key feature of the system
is that all information about prescriptions and dose
administrations are exported to a comprehensive audit
database on a weekly basis.
The hospital has prioritised measures to reduce the
occurrence of hospital-acquired VTE over the past few
years. In June 2008, a VTE risk assessment tool was intro-
duced into PICS with an alert issued to remind doctors
if the risk assessment was not completed. From June
2010, in line with the national guidelines and data col-
lection, the completion of VTE risk assessment within
the trust became mandatory for every admitted patient.
The assessment has to be completed before the patient
record and drug prescribing is enabled for that admis-
sion. Following the completion of the risk assessment, a
scheduled decision support rule is run in PICS that
reviews the current prescriptions for each patient and
automatically generates an alert where, as indicated by
the risk assessment, enoxaparin should be prescribed
but is not currently prescribed. This initial alert is dis-
played to the first prescriber to view the patient’s
medical records on PICS (this process is summarised in
figure 1) and requires a written free-text response to
explain why enoxaparin has not been prescribed (see
figure 2). Further details about the electronic VTE risk
assessment process are provided in online supplemen-
tary appendix A.
Data capture
Our outcome was the reason given for not prescribing
enoxaparin where recommended by the VTE risk assess-
ment. These responses were obtained from the enoxa-
parin free-text alert shown in figure 2. Data were
extracted from the PICS audit database on all enoxa-
parin alerts generated between 1 June 2012 and 31
December 2012. The anonymised data were extracted
into Excel for analysis.
Analysis
Four reviewers (UN, HB, SR and LM) independently
conducted preliminary content analysis of the respon-
dents’ reasons for not prescribing enoxaparin. Themes
were allowed to emerge from the data in an iterative
process, with initial themes informing and contextualis-
ing subsequent themes and vice versa. The reviewers
then met to discuss their analyses and sought to reach
consensus where the reasons were unclear. A consultant
physician ( JJC) provided clinical context to reasons that
the reviewers found difficult to categorise. The four
reviewers then independently coded the data. Whole
group discussion was used to refine coding and to iden-
tify overarching themes which helped to group
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subordinate themes, until consensus was reached.
Representation of each theme is given as the actual
number of reasons observed (some responders gave
more than one reason) and percentage of total reasons
provided.
RESULTS
During the 7-month time period, there were 37 737
admissions to the hospital. On the basis of figures from
the Trust quality account, approximately 37 340 (99%)
would have received a VTE risk assessment. A total of
1136 free-text responses were provided from 259 doctors
in response to the enoxaparin alert, which equates to
9% of the approximately 12 740 (34.1%) who were not
prescribed enoxaparin when recommended. Some
responses contained multiple reasons. As such, a total of
1206 reasons were recorded and coded.
Six main themes were identified from the reasons pro-
vided for not having prescribed enoxaparin. These
themes and the number of reasons coded within each
theme are displayed in table 1.
The reviewers coded 23.8% of the responses provided
as ‘positive response initiated’. Here, doctors indicated
that they would go on to prescribe enoxaparin after
having read the message or that they would review the
patient’s VTE risk as a result of the message. Examples
of responses are: “will review”; “will prescribe”; “oversight
—prescribed by myself today.”
The most common type of reason given for not pre-
scribing enoxaparin was due to ‘clinical judgment’, and
represents 32.3% of the reasons given. The ‘clinical
judgment’ theme can be further broken down into five
main categories: clinical reason; patient mobile; patient
discharged or soon to be discharged; patient at risk of
bleeding; and patient at risk of falls. The distribution of
these reasons (as a percentage of all clinical judgment
coded reasons) can be seen in table 2. The category of
‘clinical reason’ refers to a broad range of reasons which
are either:
▸ An explicit clinical judgment, for example, “not
required,” “end of life care. no benefit from enoxa-
parin” and “consultant decision”;
▸ Situation-specific such as “liver failure,” “stroke” and
“bleeding ulcer” or
▸ Where further information was needed before a full
assessment could be made, for example, “clinical
information still pending,” “awaiting blood results”
and “low Hb? cause.”
A fifth of the free-text reasons were coded as ‘system’
and reflect those alerts deemed as being generated
inappropriately or caused by a system error which led to
the production of the alert. Responses coded as ‘system’
often reflected cases where enoxaparin had been pre-
scribed after the alert had been generated on day 1, but
before a reason had been given. If the rules-based alert
is ignored or closed, it will continue to appear to subse-
quent prescribers logging on to the patient record.
Currently, the rules-base alert is not cancelled by the
system automatically if an appropriate prescription is
made in the interim. Examples of free-text responses
include “already prescribed,” “it is,” “has been” and
“enoxaparin prescribed.” In some cases, the free-text
reason was indicative of users’ frustrations with these
persistent alerts. For example, this was demonstrated by
the use of multiple exclamation marks in 29 out of 246
(11.8%) ‘system’ reasons. Furthermore, some users
overtly stated their frustration with the alert. For
example, “It’s been prescribed so this message is some-
thing of a frustration” and “It is prescribed—PICS giving
false warning x 3.”
The theme ‘surgery’ (11.5% of reasons given) refers
to the patient being in the perioperative period or
undergoing a specific surgical procedure where it was
thought that prescribing enoxaparin was not appropri-
ate. For example, free-text responses included “not
meant to have enox until 12 hours post surgery—accord-
ing to protocol,” “post operative—for review” and “on
theatre list today.” Additionally, some reasons alluded to
inappropriate prescribing of enoxaparin as a result of
Figure 1 Flow diagram of venous thromboembolism (VTE) alert production.
Figure 2 Initial enoxaparin alert (free-text alert; LMWH, low
molecular weight heparin; VTE, venous thromboembolism).
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the patient’s postoperative condition: “late operation yes-
terday with post-op haematoma” and “Post neurosurgery.
Bleeding around EVD site.”
The theme ‘ambiguous’ (6.7% of responses) refers to
cases which did not relate to a clinical indication or
process such as “not yet reviewed” or “patient not known
to me” or simply “don’t know.” Finally, 5.3% of the
reasons were coded as ‘drug contraindication’ as the
patient had (since the VTE risk assessment) been pre-
scribed a drug with a similar action, such as warfarin or
heparin. The rules-base does not check for such pre-
scriptions, as the risk assessment is specific in recom-
mending enoxaparin.
DISCUSSION
In a quarter of cases where a free-text response was pro-
vided, the system succeeded in prompting either a
repeat review of the patient or a prescription of enoxa-
parin where it had been overlooked or delayed. In these
cases, the alert produced the positive response that was
intended by its implementation.
The main reasons for not prescribing enoxaparin
when recommended were due to ‘clinical judgment’. As
the use of any such tool is not intended to replace
clinical judgment, we would have expected that clini-
cians would delay or avoid prescribing VTE prophylaxis
until the patient has been fully assessed. The tool is,
however, designed to provide decision support deemed
appropriate for the majority of cases. It may be prudent
to wait until test results return and a more complete
picture emerges of the patient’s condition. Clearly, com-
plete compliance with the recommendations before all
information is assessed would be just as dangerous as
poor compliance.
Where the system or process does not seem to work as
well is when it produces a seemingly inappropriate alert.
Of concern were the responses (20.4%) that indicated
doctors felt there had been a system error which had
led to inappropriate or inaccurate alert generation. A
lack of specificity in the alerting process can result in
doctors unnecessarily being alerted when, for example,
a patient has already been prescribed a lower than
recommended dose of enoxaparin as per their thera-
peutic needs or where enoxaparin is not prescribed as
the patient is to undergo surgery.
Despite the risk assessment algorithm incorporating
details of the surgery the patient was about to have
(alongside the likely duration and likelihood of
decreased mobility), 11% of the reasons for not pre-
scribing were due to the timing of the surgery and the
type of surgery. Surgical VTE risk assessments require a
complex algorithm to capture the types of surgery, the
patient’s condition and risks of bleeding therein. The
electronic risk assessment is completed within the first
few hours of admission and it would seem from the
responses that the delay or avoidance in prescribing
enoxaparin stems from the perceived risk of major
bleeding linked with certain surgical procedures and
with the timing of the alert. When alerts are produced
preoperatively, there may be an expectation that VTE
prophylaxis will be given in theatre after surgery or, in
cases where the alert is read postoperatively, the patient
has returned to the ward after having been administered
VTE prophylaxis as per protocol or indeed may have
postoperative complications that rule out pharmaco-
logical prophylaxis. An established parallel system exists
for surgical patients outside of the ward area, and the
timing of the free text and daily reminder alerts pro-
duced will not be sensitive to timing issues (eg, delayed
theatre list) or changes in a patient’s risk of bleeding
(eg, postoperative complications).
This lack of specificity of the alerts produced by VTE
risk assessment leads to the question of whether is it better
to have irrelevant alerts rather than no alerts. Specificity
could be increased by including a check for prescriptions
of warfarin or unfractionated heparin as contraindications
to prescribing enoxaparin or preventing the generation of
the alert no matter what dosage of enoxaparin is pre-
scribed. This would reduce the number of alerts produced
where an alternative anticoagulant is already prescribed or
where enoxaparin is prescribed at a different dosage,
thereby reducing inappropriate alerting. It is noteworthy


















Drug contraindication 64 5.3
Total 1206 100
Table 2 Frequency of reasons for not prescribing










Clinical reason 120 30.8
Patient mobile 111 28.5
Discharge* 84 21.6
Risk of bleeding† 64 16.5
Falls risk 10 2.6
Total 389 100
*Patient about to be discharged or had been discharged by the
time of the alert.
†Patient under investigation for bleeding risk or known condition.
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that a prescription of warfarin or a patient being already
given anticoagulants is part of the VTE risk assessment
process—and the correct recording of this would contra-
indicate enoxaparin and suppress subsequent alerts.
The timing of the alert can be an issue, for example,
when clinicians are presented with the free-text alert
even when an enoxaparin prescription is visible on the
system. To the clinician, the alert has been generated
inappropriately, but this does not provide a full picture.
Of note, the system only cross-checks for an enoxaparin
prescription once per day at 07:30. Therefore, when the
free-text alert (figure 2) is bypassed on day 1 (so-called
‘third-party ignore’), it will be shown again on day 1 to
other (or the same) clinicians who next access the
patient’s record regardless of whether enoxaparin has
since been prescribed. For example, if an enoxaparin
prescription has been written during the morning ward
round and no response is entered to the free-text alert,
the alert will still be shown the next time the patient’s
record is accessed. As long as no free-text response is
entered that day and enoxaparin has not been pre-
scribed, the daily reminder (figure 3) and the free-text
alert will reappear on day 2 when the system cross-
checks the prescription data. Despite causing some frus-
tration, allowing third-party dismissal of alerts means
that it can still be visible to clinicians directly responsible
for the patient’s care. This frustration may be unavoid-
able in some cases as the alert is presented to anyone
with authorisation to prescribe. In the case of bank/
locum doctors or those who are not familiar with the
patient, they may be unaware of the reason that enoxa-
parin has not been prescribed and therefore may not
respond appropriately (eg, they may just be logging on
to PICS to familiarise themselves with the patient prior
to meeting them). The only way to truly avoid this is to
change the system to check for a prescription prior to
each presentation of the alert.
What is of concern is the likelihood of fatigue due to
excessive alerts and workarounds, especially when the
mechanisms behind the alert generation are not under-
stood. We found four examples in the data of clinicians
entering full stops in the free-text field to make the alert
recede (3 by the same clinician). Frustration is often sec-
ondary to inappropriate use of the system, for example,
failure to acknowledge alerts even when doing the
correct thing or not noting options in the risk assess-
ment which would suppress future alerts.
Limitations
In this research, we have obtained information regard-
ing the real-time reasons and feedback from responses
left during the workflow. This allows for a deeper under-
standing of user experiences and how the VTE alerts
within the electronic prescribing system are received.
What is particularly useful is that we have examined data
regarding the free-text alerts for the first 7 months after
its initial implementation, meaning that our findings
will allow us to give feedback and make changes to the
system if and where appropriate. This evaluation of our
own system may lead to improvements which we can
then share with other system providers.
Nonetheless, in this study, we are unable to take into
account those cases in which no free-text response was pro-
vided at all. The system was effective in prompting doctors
to provide a reason for not prescribing enoxaparin in 1136
cases. In the remaining approximately 11 600 cases where
no free-text response was obtained, this may be attributed
to patients being discharged prior to the free-text alert
being triggered. Furthermore, from our data, we are unable
to determine whether the responses that are provided by
doctors are reliable (ie, honest) or if there are more
complex reasons behind not having prescribed enoxaparin.
For example, some responses are written in capital letters
and it is not possible to tell whether this is done due to frus-
tration or whether it is a default by the keyboard that the
doctor is using. Other incomplete responses meant that we
were not provided with information that we could utilise in
our analysis. We are also unable to determine whether a
prescription was actioned even when a positive response to
the free-text alert was given. Finally, the single site nature of
the study further limits the generalisability of the findings.
To follow on from this research, it would be useful to
organise discussion groups or forums in which doctors
can verbally discuss their perceptions of the VTE alerts
(and perhaps decision support warnings more generally)
and provide some more context to their responses.
Alternatively, it may be interesting to shadow doctors on
the ward and observe their response as they use the
system and as alerts are generated. Furthermore, it
might be useful to investigate the process of VTE assess-
ment and appropriate anticoagulant prescription for sur-
gical patients in more detail. This might help to
establish whether it may be necessary to design a parallel
system for these patients, which may lead to the prescrip-
tion being made/decision not to prescribe due to the
time of surgery. It might be interesting to utilise stealth
alerts/stealth processes24 through a third party in order
to alert the patient’s regular doctor/consultant to a lack
of VTE prophylaxis or, for example, alert a pharmacist
to check the dose where an enoxaparin prescription isFigure 3 Subsequent enoxaparin alert.
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present but the dose is not what would normally be
recommended.
The ultimate aim of using the electronic prescribing
system is to improve patient safety by receiving appropriate
VTE risk assessment and treatment. Since this study was
conducted, the system has been updated so that doctors
are now automatically taken to a blank prescription page if
enoxaparin is recommended following the VTE risk assess-
ment. System improvements such as this are required to
support the assessment processes, prescriber engagement
and education to take the appropriate action.
CONCLUSION
This study examined the free-text reasons given by doctors
when they have not yet prescribed the prophylaxis sug-
gested by the VTE risk assessment tool. The analysis shows
that doctors bypass the recommendations because they are
rationalising the VTE risk and use of prophylaxis on the
emerging picture of the patient’s condition on the one
hand, and they become frustrated with the system because
of lack of training on the other. Understanding why
doctors use workarounds will enable healthcare providers
to modify systems or training programmes to reduce alert
fatigue while optimising the appropriateness of CDS alerts.
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